Filing Details

Accession Number:
0001555794-15-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-07 11:57:43
Reporting Period:
2015-12-03
Filing Date:
2015-12-07
Accepted Time:
2015-12-07 11:57:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555794 Lan Xie 950 Tower Lane, Suite 900
Foster City CA 94404
Vp Finance, China Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-03 4,166 $4.52 4,166 No 4 M Direct
Common Stock Disposition 2015-12-03 4,166 $9.50 0 No 4 S Direct
Common Stock Acquisiton 2015-12-03 1,875 $4.53 1,875 No 4 M Direct
Common Stock Disposition 2015-12-03 1,875 $9.50 0 No 4 S Direct
Common Stock Acquisiton 2015-12-03 8,125 $5.19 8,125 No 4 M Direct
Common Stock Disposition 2015-12-03 8,125 $9.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-12-03 4,166 $0.00 4,166 $4.52
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-12-03 1,875 $0.00 1,875 $4.53
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-12-03 8,125 $0.00 8,125 $5.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,167 2024-03-14 No 4 M Direct
5,312 2023-04-04 No 4 M Direct
12,187 2022-08-01 No 4 M Direct
Footnotes
  1. Granted under the Issuer's 2005 Equity Incentive Plan.
  2. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.